1-6 of 6
Kevin L. Bennewith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B016: Targeting the angiotensin receptor in cancer-associated fibroblasts improves tumour perfusion, oxygenation, and radiotherapy response

Free
Che-Min Lee, Brennan J. Wadsworth, Rachel A. Cederberg, Zi Han Li, Kiersten N. Thomas, Meredith Clark, Rocky Shi, Michael Hall, Nikita Telkar, Ryan Urban, Wan L. Lam, Sarah N. Hamilton, Kevin L. Bennewith
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (2_Supplement): B016.
https://doi.org/10.1158/1557-3265.TARGETEDTHERAP-B016
Published: 26 January 2025
View article titled, Abstract B016: Targeting the angiotensin receptor in cancer-associated fibroblasts improves tumour perfusion, oxygenation, and radiotherapy response
Journal Articles

Abstract PR-001: Angiotensin II receptor blockers modify the solid tumor microenvironment and improve radiation therapy response

Free
Brennan J. Wadsworth, Che-Min Lee, Ryan Urban, Sarah N. Hamilton, Kevin L. Bennewith
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8_Supplement): PR-001.
https://doi.org/10.1158/1557-3265.RADSCI21-PR-001
Published: 15 April 2021
View article titled, Abstract PR-001: Angiotensin II receptor blockers modify the solid tumor microenvironment and improve radiation therapy response
Journal Articles

Abstract PO-053: Targeting focal adhesions to limit radiation-induced glioblastoma cell invasion

Free
Lisa R. Decotret, Rocky Shi, Kevin L. Bennewith
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8_Supplement): PO-053.
https://doi.org/10.1158/1557-3265.RADSCI21-PO-053
Published: 15 April 2021
View article titled, Abstract PO-053: Targeting focal adhesions to limit radiation-induced glioblastoma cell invasion
Journal Articles

Abstract PO-034: Changes in cancer associated fibroblast subsets following angiotensin II type I receptor blocker (ARB) treatment reduces transient hypoxia and radiation resistance

Free
Che-Min Lee, Brennan J. Wadsworth, Kevin L. Bennewith
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8_Supplement): PO-034.
https://doi.org/10.1158/1557-3265.RADSCI21-PO-034
Published: 15 April 2021
View article titled, Abstract PO-034: Changes in cancer associated fibroblast subsets following angiotensin II type I receptor blocker (ARB) treatment reduces transient hypoxia and radiation resistance
Journal Articles

Abstract A02: Oncogenic drivers of lung cancer induce production of CCL5 and recruitment of regulatory T-cells

Free
Elizabeth Franks, Elizabeth C. Halvorsen, Etienne Melese, Unni Arun, Jenna L. Collier, Bryant T. Harbourne, Min Hee Oh, Lam Vivian, Gerry Krystal, John C. English, Wan L. Lam, Stephen Lam, Ninan Abraham, Kevin L. Bennewith, William W. Lockwood
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (17_Supplement): A02.
https://doi.org/10.1158/1557-3265.AACRIASLC18-A02
Published: 01 September 2018
View article titled, Abstract A02: Oncogenic drivers of lung cancer induce production of CCL5 and recruitment of regulatory T-cells
Journal Articles

Pharmacologically Increased Tumor Hypoxia Can Be Measured by 18F-Fluoroazomycin Arabinoside Positron Emission Tomography and Enhances Tumor Response to Hypoxic Cytotoxin PR-104

Free
Rob A. Cairns, Kevin L. Bennewith, Edward E. Graves, Amato J. Giaccia, Daniel T. Chang, Nicholas C. Denko
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7170–7174.
https://doi.org/10.1158/1078-0432.CCR-09-1676
Published: 30 November 2009
View article titled, Pharmacologically Increased Tumor Hypoxia Can Be Measured by 18F-Fluoroazomycin Arabinoside Positron Emission Tomography and Enhances Tumor Response to Hypoxic Cytotoxin PR-104
Open the PDF for Pharmacologically Increased Tumor Hypoxia Can Be Measured by 18F-Fluoroazomycin Arabinoside Positron Emission Tomography and Enhances Tumor Response to Hypoxic Cytotoxin PR-104 in another window
Includes: Supplementary data